Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Raymond James Trust N.A.

Raymond James Trust N.A. boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.6% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 10,007 shares of the medical equipment provider’s stock after buying an additional 345 shares during the quarter. Raymond James Trust N.A.’s holdings in Intuitive Surgical were worth $4,916,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Mirador Capital Partners LP lifted its stake in Intuitive Surgical by 1.4% during the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after buying an additional 50 shares in the last quarter. Advisors Asset Management Inc. boosted its stake in Intuitive Surgical by 18.1% in the 1st quarter. Advisors Asset Management Inc. now owns 7,380 shares of the medical equipment provider’s stock worth $2,945,000 after purchasing an additional 1,129 shares during the period. Consolidated Planning Corp grew its position in Intuitive Surgical by 17.4% during the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock worth $3,979,000 after purchasing an additional 1,198 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund raised its stake in Intuitive Surgical by 617.1% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock valued at $39,622,000 after purchasing an additional 76,649 shares during the period. Finally, Swiss National Bank lifted its holdings in shares of Intuitive Surgical by 0.3% in the third quarter. Swiss National Bank now owns 1,052,800 shares of the medical equipment provider’s stock valued at $517,209,000 after purchasing an additional 3,400 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research firms have issued reports on ISRG. Redburn Atlantic upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and lifted their target price for the company from $380.00 to $510.00 in a research note on Friday, August 2nd. BTIG Research set a $535.00 target price on shares of Intuitive Surgical in a research report on Friday, October 18th. Robert W. Baird raised their target price on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday. Finally, Piper Sandler reissued an “overweight” rating and set a $538.00 price objective (up previously from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $524.61.

Intuitive Surgical Trading Down 0.5 %

NASDAQ:ISRG opened at $547.87 on Friday. The stock has a 50-day moving average price of $504.73 and a two-hundred day moving average price of $463.02. Intuitive Surgical, Inc. has a 1 year low of $304.50 and a 1 year high of $552.00. The stock has a market cap of $195.14 billion, a price-to-earnings ratio of 88.08, a PEG ratio of 5.41 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Robert Desantis sold 396 shares of Intuitive Surgical stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $486.88, for a total value of $192,804.48. Following the completion of the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,680,761.28. This trade represents a 6.71 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Amy L. Ladd sold 450 shares of the business’s stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $490.28, for a total value of $220,626.00. Following the transaction, the director now directly owns 821 shares in the company, valued at approximately $402,519.88. This trade represents a 35.41 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 50,935 shares of company stock worth $26,305,169. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.